Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03852485
Other study ID # 200-53769
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 29, 2019
Est. completion date August 30, 2019

Study information

Verified date August 2019
Source Optovue
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Comparison of OCT and OCTA-based Ocular Measurements to those of Predicate


Description:

The purpose of this study is to compare with predicate device for the measurements of vascular structures and anatomical structures of the posterior pole of the eye based on OCTA and OCT scans in normal subjects, glaucoma patients, and retina patients, and to compare with predicate device for the measurements of corneal layers based on corneal OCT scans in normal subjects and cornea patients.


Recruitment information / eligibility

Status Completed
Enrollment 199
Est. completion date August 30, 2019
Est. primary completion date August 2, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility IInclusion Criteria:

- Normal - No glaucoma or treatment to lower IOP or retinal pathology for posterior imaging; No contact lens wear, dry eye, anterior pathology or ocular surgery for corneal imaging.

- Glaucoma - Have glaucoma and no history of other retinal pathology.

- Retina - Have retinal pathology and no history of glaucoma or treatment to lower IOP.

- Cornea - Contact lens wear or corneal condition such as dry eye, KCN, or post refractive surgery.

Exclusion Criteria:

- Normal - Unable to complete required exams; Clinical finding of posterior pathology or VA worse than 20/40 for posterior imaging; Clinical findings of corneal condition for corneal imaging.

- Glaucoma - Unable to complete required exams; Clinical signs of retinal pathology.

- Retina - Unable to complete required exams.

- Cornea - Unable to complete required exams.

Study Design


Related Conditions & MeSH terms

  • Normal Eyes and Eyes With Ocular Pathologies

Intervention

Device:
SD-OCT
Spectral Domain Optical Coherence Tomography for non-invasive, light-based, cross-sectional imaging of ocular structures

Locations

Country Name City State
United States AMA Marysville Ohio
United States IOVS Newark New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Optovue

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Limits of agreement estimation of the interval within which a proportion of the differences between measurements lie Day 1
Secondary Regression Analysis statistical process for estimating the relationships among variables Day 1